missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. Chymotrypsin C/CTRC Antibody, Novus Biologicals™

Chymotrypsin C/CTRC Antibody, Novus Biologicals™

Rabbit Polyclonal Antibody

£381.00

Specifications

Antigen Chymotrypsin C/CTRC
Applications Western Blot
Classification Polyclonal
Conjugate Unconjugated
Host Species Rabbit
View More Specs

Products 1
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
18283201
View Documents
missing translation for 'viewProductCertificates'
Novus Biologicals
NBP1-58035 		100 μL
£381.00
100µL
View alternative products
Save Up to  »
Please to purchase this item. Need a web account? Register with us today!
Description

Description

Chymotrypsin C/CTRC Polyclonal specifically detects Chymotrypsin C/CTRC in Human samples. It is validated for Western Blot.
Specifications

Specifications

Chymotrypsin C/CTRC
Polyclonal
Rabbit
Q99895
11330
Synthetic peptides corresponding to CTRC(chymotrypsin C (caldecrin)) The peptide sequence was selected from the N terminal of CTRC. Peptide sequence LGITVLAALLACASSCGVPSFPPNLSARVVGGEDARPHSWPWQISLQYLK.
Primary
Western Blot
Unconjugated
RUO
Caldecrin, chymotrypsin C (caldecrin), chymotrypsin-C, CLCRserum calcium decreasing factor, EC 3.4.21, EC 3.4.21.2, ELA4, elastase 4, elastase IV
CTRC
IgG
27 kDa
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.